NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc. (NRXP): 4 pipeline candidates · ~5 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
4.8 months
D/E -1.86 · 0% dilution
Lead: BLA Filed
4 candidates
N/A
N/A
A transparent, data-derived signal for NRX Pharmaceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$170.3M
Cash
$6.7M
Quarterly Burn
$4.3M
Runway
4.8 mo
Revenue
$1.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
32
Total value held
$9.5M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 2,320,368 | $4.9M |
| advisorshares investments llc | 420,467 | $896K |
| commonwealth equity services, llc | 397,431 | $847K |
| geode capital management, llc | 310,112 | $661K |
| jane street group, llc | 180,652 | $385K |
| vanguard fiduciary trust co | 169,580 | $361K |
| susquehanna international group, llp | 102,200 | $218K |
| blackrock, inc. | 98,995 | $211K |
| state street corp | 86,984 | $185K |
| xtx topco ltd | 78,733 | $168K |
Showing top 10 of 32 institutional holders of NRX Pharmaceuticals Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in NRX Pharmaceuticals Inc.'s pipeline?
NRX Pharmaceuticals Inc. (NRXP) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is NRX Pharmaceuticals Inc.'s lead drug candidate?
NRX Pharmaceuticals Inc.'s most advanced tracked candidate is htx-100 (Preclinical) for Suicidal depression, PTSD, and other serious Central Nervous System (CNS) disorders.
What is NRX Pharmaceuticals Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, NRX Pharmaceuticals Inc. has approximately 4.8 months of cash runway.
What is NRX Pharmaceuticals Inc.'s market capitalization?
NRX Pharmaceuticals Inc.'s market capitalization is approximately $170.3M.
Who is the CEO of NRX Pharmaceuticals Inc.?
Dr. Jonathan C. Javitt M.D., M.P.H. is the chief executive officer of NRX Pharmaceuticals Inc. (NRXP).
Get the full picture on NRX Pharmaceuticals Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.